In short
Floxuridine, also known as FUDR, is being investigated in several clinical trials as a treatment for colorectal cancer that has spread to the liver. This article summarizes key information about ongoing research into floxuridine's use in hepatic arterial infusion chemotherapy and other approaches for patients with colorectal liver metastases.
At a glance
- Primary Use
- Treatment of colorectal liver metastases
- Administration Method
- Hepatic arterial infusion (HAI) via implanted pump
- Common Combinations
- With systemic chemotherapy (e.g., oxaliplatin, irinotecan, capecitabine)
- Patient Population
- Unresectable liver metastases, often after progression on first-line therapy
- Key Outcomes Measured
- Tumor response, resection rates, progression-free interval, overall survival
- Potential Advantages
- Higher local drug concentrations, potentially improved tumor response
- Challenges
- Requires surgical pump placement, potential for hepatobiliary toxicity
- Current Status
- Under investigation in multiple phase II and III clinical trials
What is Floxuridine?
Floxuridine, also known as FUDR, is a chemotherapy drug used in the treatment of various cancers. It belongs to a class of medications called antimetabolites, which work by interfering with the growth of cancer cells. Floxuridine is particularly effective in treating liver cancers because it has a very high first-pass extraction (about 95%) in the liver, meaning that most of the drug is absorbed and used by the liver before entering the general circulation.
What Conditions Does Floxuridine Treat?
Floxuridine is primarily used to treat the following conditions:
- Colorectal Liver Metastases (CRLM): This refers to cancer that has spread from the colon or rectum to the liver.
- Hepatocellular Carcinoma (HCC): A type of primary liver cancer.
- Intrahepatic Cholangiocarcinoma (ICC): A cancer that forms in the bile ducts within the liver.
- Gastric Cancer: Cancer that begins in the stomach.
How is Floxuridine Administered?
Floxuridine is typically administered through a method called Hepatic Arterial Infusion (HAI). This involves:
- Surgical Procedure: A catheter (thin tube) is placed directly into the hepatic artery, which supplies blood to the liver.
- Pump Placement: The catheter is connected to a small pump that is surgically implanted under the skin of the abdomen.
- Continuous Infusion: The pump delivers floxuridine directly to the liver over a period of time, usually 14 days.
This method allows for a high concentration of the drug to be delivered directly to the liver while minimizing exposure to the rest of the body, potentially reducing side effects.
Floxuridine in Combination Therapies
Floxuridine is often used in combination with other drugs to enhance its effectiveness. Some common combinations include:
- Floxuridine + Dexamethasone: Dexamethasone is a steroid that helps reduce inflammation and may enhance the effects of floxuridine.
- Floxuridine + Oxaliplatin: Oxaliplatin is another chemotherapy drug that can be used in combination with floxuridine to treat colorectal liver metastases.
- Floxuridine + Irinotecan: Irinotecan is a chemotherapy drug that can be used systemically (throughout the body) while floxuridine is administered via HAI.
- Floxuridine + Capecitabine + Oxaliplatin: This three-drug combination is being studied for its effectiveness in treating colorectal liver metastases.
Current Clinical Trials Using Floxuridine
Several clinical trials are ongoing to further investigate the effectiveness of floxuridine in various scenarios:
- A study comparing HAI floxuridine plus systemic chemotherapy to systemic chemotherapy alone in patients with colorectal liver metastases.
- A trial examining the use of floxuridine in combination with oxaliplatin and irinotecan for patients with initially unresectable colorectal liver metastases.
- Research on using floxuridine as part of adjuvant therapy (treatment given after surgery) for patients who have had liver metastases removed.
Potential Side Effects
While HAI administration of floxuridine can help minimize systemic side effects, patients may still experience some adverse reactions. These can include:
- Liver function changes: Regular blood tests are done to monitor liver health.
- Biliary inflammation or necrosis: In rare cases, floxuridine can cause inflammation or damage to the bile ducts. This risk is reduced by adding dexamethasone to the infusion.
- Pump-related complications: Issues with the pump or catheter may occur, requiring medical attention.
It's important to discuss potential side effects and their management with your healthcare team before starting treatment with floxuridine.